Edition:
United Kingdom

ChemoCentryx Inc (CCXI.OQ)

CCXI.OQ on NASDAQ Stock Exchange Global Select Market

12.24USD
18 May 2018
Change (% chg)

$-0.23 (-1.84%)
Prev Close
$12.47
Open
$12.57
Day's High
$12.57
Day's Low
$11.92
Volume
60,936
Avg. Vol
79,959
52-wk High
$15.08
52-wk Low
$5.45

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.23 December 23 May 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 0 0 0
(2) OUTPERFORM 3 2 2 2
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.33 2.33 2.33

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 5 9.56 10.00 9.00 --
Quarter Ending Sep-18 5 9.62 10.00 9.00 --
Year Ending Dec-18 5 38.10 39.30 36.50 33.17
Year Ending Dec-19 5 48.08 68.40 41.00 30.53
Earnings (per share)
Quarter Ending Jun-18 5 -0.23 -0.21 -0.28 --
Quarter Ending Sep-18 5 -0.25 -0.22 -0.30 --
Year Ending Dec-18 5 -0.94 -0.85 -1.10 -0.92
Year Ending Dec-19 5 -0.86 0.22 -1.37 -0.96

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 7.00 9.55 2.55 36.37
Quarter Ending Dec-17 9.40 56.30 46.90 498.95
Quarter Ending Sep-17 9.03 9.03 0.00 0.05
Quarter Ending Jun-17 8.50 8.94 0.44 5.14
Quarter Ending Mar-17 5.30 8.23 2.93 55.28

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 9.56 9.57 9.37 9.37 --
Quarter Ending Sep-18 9.62 9.65 9.43 9.43 --
Year Ending Dec-18 38.10 38.08 34.63 34.63 33.17
Year Ending Dec-19 48.08 48.60 46.97 46.97 30.53

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 1 1
Quarter Ending Sep-18 0 0 1 1
Year Ending Dec-18 0 0 2 1
Year Ending Dec-19 0 0 1 1
Earnings